ARCUS BIOSCIENCES

arcus-biosciences-logo

Arcus Biosciences is an oncology-focused clinical-stage biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer. It aims to create new cancer therapeutics through the utilization of emerging insights in immunology. The company has four molecules in clinical development: Etrumadenant (AB928), the first dual A2a/A2b adenosine receptor antagonist to enter the clinic, is being evaluated in multiple Phase 2 and 1b studies across different in... dications, including prostate, colorectal, non-small cell lung, pancreatic and triple-negative breast cancers. AB680, the first small-molecule CD73 inhibitor to enter the clinic, is in Phase 1/1b development for first-line treatment of metastatic pancreatic cancer in combination with zimberelimab and gemcitabine/nab-paclitaxel. Domvanalimab (AB154), an anti-TIGIT monoclonal antibody and new potential immuno-oncology backbone therapy, is in a three-arm randomized Phase 2 study for first-line treatment of PD-L1-high metastatic non-small cell lung cancer (NSCLC) evaluating zimberelimab monotherapy, domvanalimab with zimberelimab and domvanalimab plus AB928 with zimberelimab. AB308, an anti-TIGIT antibody that is FcR enabled, is advancing into clinical development to investigate additional indications, with a focus on hematological malignancies. Zimberelimab (AB122), Arcus’s anti-PD-1 monoclonal antibody, was in-licensed to enable the development of Arcus’s combination regimens and is being evaluated in various combinations across the portfolio. Arcus was formed in 2015 in Hayward, California by Terry Rosen and Juan Jaen.

#SimilarOrganizations #People #Financial #Event #Website #More

ARCUS BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2015-01-01

Address:
Hayward, California, United States

Country:
United States

Website Url:
http://www.arcusbio.com

Total Employee:
101+

Status:
Active

Contact:
+1 510-694-6200

Email Addresses:
[email protected]

Total Funding:
647.05 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Wordpress Plugins


Similar Organizations

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

cogent-biosciences-logo

Cogent Biosciences

Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.


Current Advisors List

yasunori-kaneko_image

Yasunori Kaneko Board Member @ Arcus Biosciences
Board_member

blake-byers_image

Blake Byers Board Observer @ Arcus Biosciences
Board_observer
2016-01-01

kristen-hege_image

Kristen Hege Board Member @ Arcus Biosciences
Board_member

terry-rosen_image

Terry Rosen Board Member @ Arcus Biosciences
Board_member

kathryn-e-falberg_image

Kathryn E. Falberg Board Member @ Arcus Biosciences
Board_member
2014-02-01

jennifer-jarrett_image

Jennifer Jarrett Board Member @ Arcus Biosciences
Board_member

juan-jaen_image

Juan Jaen Board Member @ Arcus Biosciences
Board_member

david-beier_image

David Beier Board Member @ Arcus Biosciences
Board_member
2017-12-01

Current Employees Featured

william-grossman_image

William Grossman
William Grossman Chief Medical Officer @ Arcus Biosciences
Chief Medical Officer
2019-05-01

nick-giafis_image

Nick Giafis
Nick Giafis Vice President of Medical Affairs @ Arcus Biosciences
Vice President of Medical Affairs

jennifer-jarrett_image

Jennifer Jarrett
Jennifer Jarrett COO @ Arcus Biosciences
COO

patricia-carlos_image

Patricia Carlos
Patricia Carlos VP of Regulatory Affairs @ Arcus Biosciences
VP of Regulatory Affairs

katherine-bock_image

Katherine Bock
Katherine Bock VP of Investor Relations and Corporate Strategy @ Arcus Biosciences
VP of Investor Relations and Corporate Strategy

steve-young_image

Steve Young
Steve Young SVP of Technology and Quantitative Biology @ Arcus Biosciences
SVP of Technology and Quantitative Biology

nigel-walker_image

Nigel Walker
Nigel Walker SVP of Protein Therapeutics @ Arcus Biosciences
SVP of Protein Therapeutics

juan-jaen_image

Juan Jaen
Juan Jaen President & Co-Founder @ Arcus Biosciences
President & Co-Founder
2015-07-01

dimitry-nuyten_image

Dimitry Nuyten
Dimitry Nuyten Chief Medical Officer @ Arcus Biosciences
Chief Medical Officer
2022-08-01

not_available_image

Jonathan Yingling
Jonathan Yingling SVP of Research @ Arcus Biosciences
SVP of Research

Founder


juan-jaen_image

Juan Jaen

terry-rosen_image

Terry Rosen

Stock Details


Company's stock symbol is NYSE:RCUS

Investors List

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Post-IPO Equity - Arcus Biosciences

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Post-IPO Equity - Arcus Biosciences

the-column-group_image

The Column Group

The Column Group investment in Series C - Arcus Biosciences

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Series C - Arcus Biosciences

decheng-capital_image

Decheng Capital

Decheng Capital investment in Series C - Arcus Biosciences

droia_image

Droia Ventures

Droia Ventures investment in Series C - Arcus Biosciences

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series C - Arcus Biosciences

taiho-ventures-2_image

Taiho Ventures

Taiho Ventures investment in Series C - Arcus Biosciences

celgene_image

Celgene

Celgene investment in Series C - Arcus Biosciences

leerink-partners_image

Leerink Partners

Leerink Partners investment in Series C - Arcus Biosciences

Official Site Inspections

http://www.arcusbio.com Semrush global rank: 1.76 M Semrush visits lastest month: 13.27 K

  • Host name: 141.193.213.21
  • IP address: 141.193.213.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Arcus Biosciences" on Search Engine